Third, additional experiments are warranted to validate dyslipidemia as the link between AP and T2DM and to investigate the mechanisms of SLPI and ARHGEF9 in AP and T2DM and their relationship with dyslipidemia. The gene discussed is SLPI; the disease is metabolic syndrome.